Don't Just Read the News, Understand It.
Get Started
SubscribeLogin
Israel-Hamas Conflict
NHL
Social Media
World Cup
Formula 1
Music
Natural Disasters
Work
Donald Trump
Amazon
NBA
Artificial Intelligence
Immigration
Published • loading... • Updated

Frontline Ibrutinib/Venetoclax Yields Response in Older Patients With MCL

Summary by oncnursingnews.com
The frontline combination of ibrutinib with venetoclax was associated with complete response and durable remission for older patients with MCL.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
oncnursingnews.comoncnursingnews.com

Frontline Ibrutinib/Venetoclax Yields Response in Older Patients With MCL

The frontline combination of ibrutinib with venetoclax was associated with complete response and durable remission for older patients with MCL.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

oncnursingnews.com broke the news in on Thursday, June 26, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

You have read 1 out of your 5 free daily articles.

Join millions of well-informed readers who use Ground to compare coverage, check their news blindspots, and challenge their worldview.

News
For You
SearchBlindspotLocal